Illumina Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 11/29/2023
Illumina Inc Stock Forecast and Price Target
According to fourteen experts, who recently provided their 2023 price targets for Illumina Inc, the average price target is $140.00, with a high estimate of $260.00 and a low estimate of $50.00. That is a potential upside of approximately 45.02% from the last closing price of $96.54 on November, 2023. If you are not interested in ILMN stock, you may still be interested in its competitors and their current standings.
45.02% Upside
Illumina Inc Fair Value Forecast for 2023 - 2025 - 2030
In the last five years, Illumina Inc has seen a decline in its Price, from $379.75 to $0.00 – a 100.00% decrease. In the next year, analysts expect Fair Value to reach $349.88 – an increase of 100.00%. For the next eight years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific Inc | Outperform |
10
|
$485.92 | Buy/Sell | $532.68 | 9.07% |
| DHR Stock Forecast | Danaher Corp | Outperform |
10
|
$218.76 | Buy/Sell | $245.74 | 9.48% |
| A Stock Forecast | Agilent Technologies | Outperform |
17
|
$124.71 | Buy/Sell | $132.86 | 8.25% |
| MTD Stock Forecast | Mettler-Toledo International I... | Hold |
13
|
$1.08k | Buy/Sell | $1.39k | -2.97% |
| WAT Stock Forecast | Waters Corp | Hold |
15
|
$275.95 | Buy/Sell | $272.06 | -2.16% |
Illumina Inc Revenue Forecast for 2023 - 2025 - 2030
Illumina Inc's Revenue has increased by 37.53% In the last five years, going from $3.33B to $4.58B. In the next year, analysts expect Revenue to reach $6.07B – an increase of 32.40%. For the next eight years, the forecast is for Revenue to grow by 335.39%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AVTR Stock Forecast | Avantor | Outperform |
16
|
$20.44 | Buy/Sell | $0.00 | 12.52% |
| PKI Stock Forecast | PerkinElmer | Outperform |
16
|
$87.75 | Buy/Sell | $136.07 | 19.09% |
| BRKR Stock Forecast | Bruker Corp | Outperform |
16
|
$64.16 | Buy/Sell | $79.22 | 12.22% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIO Stock Forecast | Bio-Rad Laboratories Inc | Buy |
16
|
$304.40 | Buy/Sell | $536.80 | 44.88% |
| COHR Stock Forecast | Coherent | - |
12
|
$33.97 | Buy/Sell | $258.00 | -100.00% |
| PACB Stock Forecast | Pacific Biosciences of Califor... | Outperform |
9
|
$8.63 | Buy/Sell | $12.67 | 21.67% |
Illumina Inc Free Cash Flow Forecast for 2023 - 2025 - 2030
Illumina Inc's Free Cash Flow has decreased In the last five years, from $846.00M to $-4041.00T – a 477659708.27% drop. In the following year, 5 experts forecast Illumina Inc's Free Cash Flow will decrease by 100.00%, to $960.89M. In 2030, professionals predict that Illumina Inc's Free Cash Flow will decrease by 100.00%, to $4.95B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FLDM Stock Forecast | Fluidigm | Buy |
11
|
$2.45 | Buy/Sell | $12.00 | 63.27% |
| HBIO Stock Forecast | Harvard Bioscience Inc | Buy |
14
|
$4.29 | Buy/Sell | $10.00 | 63.17% |
| EQTL Stock Forecast | Equitech International | - |
0
|
$1.75 | Buy/Sell | $0.00 | -100.00% |
Illumina Inc Net Income Forecast for 2023 - 2025 - 2030
In the last five years, Illumina Inc's Net Income has fallen from $826.00M to $-4.40B – a 633.17% decrease. According to 13 prominent analysts, Illumina Inc's Net Income will fall by 119.12% in the next year, reaching $842.18M. By 2030, professionals believe that Illumina Inc's Net Income will decrease by 241.24%, reaching $6.22B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ASPT Stock Forecast | Haber | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| MDIT Stock Forecast | Medite Cancer Diagnostics | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| OMRX Stock Forecast | Orthometrix | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
Illumina Inc EBITDA Forecast for 2023 - 2025 - 2030
In the last five years, Illumina Inc's EBITDA has grown by 360.17%, rising from $1.06B to $4.89B. According to 9 major analysts, Illumina Inc's EBITDA will fall by 73.47% in the next year, reaching $1.30B. Over the next eight years, experts predict that Illumina Inc's EBITDA will grow at a rate of 71.88%.
Illumina Inc EBIT Forecast for 2023 - 2025 - 2030
In the last four years, Illumina Inc's EBIT has gone down from $883.00M to $179.00M – a 79.73% drop. For next year, analysts predict EBIT of $1.05B, which would mean an increase of 485.26%. Over the next eight years, experts predict that Illumina Inc's EBIT will grow at a rate of 2782.46%.
Illumina Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last five years, Illumina Inc has seen a decline in its EPS, from $5.72 to $-28.00 – a 589.51% decrease. According to the 18 analysts polled, in the next year, Illumina Inc's EPS will fall by 118.82%, reaching $5.27. By 2030, professionals believe that Illumina Inc's EPS will have decreased by 273.79%, falling to $48.66.
.jpg)